Abstract

INTRODUCTION: A recent large prospective study found the pregnancy-adapted YEARS algorithm to be an effective screening tool for pregnant women with suspected pulmonary embolism (PE) while reducing the number of CT pulmonary angiography (CTPA). We investigated the cost-effectiveness of using the YEARS algorithm compared to the current standard. METHODS: A cost-effectiveness model was built using TreeAge software to compare the YEARS algorithm versus the current standard where all women get a CTPA. We used a theoretical cohort of 35,000 women, the estimated number of pregnant women in the US who are evaluated for a PE each year. Outcomes included costs, quality-adjusted life years (QALY’s) for the mother, maternal death, childhood cancer, and missed PE’s. Probabilities were derived from the literature. Cost-effectiveness threshold was set at $100,0000/QALY. Sensitivity analyses were done to evaluate the robustness of the results. RESULTS: In our theoretical cohort, the pregnancy-adapted YEARS algorithm resulted in a savings of $5,923,530 per year and higher QALYs. There were 42 fewer cases of childhood cancer and 4 more maternal deaths despite 361 missed PE cases. CONCLUSION: In our theoretical cohort, utilizing the pregnancy-adapted YEARS algorithm resulted in lower costs and increased QALYs. These results should be considered as future guidelines regarding the evaluation of pregnant women with suspected PE’s are established.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call